Similar articles

• Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.

  Zittoun R, Marie JP, Zittoun J, Marquet J, Haanen C. Zittoun R, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):139-43. Semin Oncol. 1985. PMID: 3859928 No abstract available.
• High-dose cytosine arabinoside in the treatment of childhood malignancies.

  Lie SO, Slørdahl S. Lie SO, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):160-5. Semin Oncol. 1985. PMID: 3859931 No abstract available.
• [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].

  Schwarzenberg L, Mathé G, Hayat M, de Vassal F, Amiel JL, Cattan A, Schneider M, Schlumberger JR, Rosenfeld C, Jasmin C. Schwarzenberg L, et al. Nouv Rev Fr Hematol. 1969 Mar-Apr;9(2):199-204. Nouv Rev Fr Hematol. 1969. PMID: 4239783 French. No abstract available.
• High-dose cytosine arabinoside: pharmacological and clinical aspects.

  Peters WG, Colly LP, Willemze R. Peters WG, et al. Blut. 1988 Jan;56(1):1-11. doi: 10.1007/BF00321053. Blut. 1988. PMID: 3276364 Review. No abstract available.
• [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].

  Brodzki LM. Brodzki LM. Acta Haematol Pol. 1985 Jan-Jun;16(1-2):85-9. Acta Haematol Pol. 1985. PMID: 3914171 Review. Polish. No abstract available.